The China Mail - US abortion ruling threatens access to arthritis drug

USD -
AED 3.672504
AFN 66.344071
ALL 83.58702
AMD 382.869053
ANG 1.789982
AOA 917.000367
ARS 1405.057166
AUD 1.540832
AWG 1.805
AZN 1.70397
BAM 1.691481
BBD 2.013336
BDT 122.007014
BGN 1.69079
BHD 0.374011
BIF 2943.839757
BMD 1
BND 1.3018
BOB 6.91701
BRL 5.332404
BSD 0.999615
BTN 88.59887
BWP 13.420625
BYN 3.406804
BYR 19600
BZD 2.010326
CAD 1.40485
CDF 2150.000362
CHF 0.80538
CLF 0.024066
CLP 944.120396
CNY 7.11935
CNH 7.12515
COP 3780
CRC 501.883251
CUC 1
CUP 26.5
CVE 95.363087
CZK 21.009504
DJF 177.720393
DKK 6.457204
DOP 64.223754
DZD 129.411663
EGP 46.950698
ERN 15
ETB 154.306137
EUR 0.86435
FJD 2.28425
FKP 0.759642
GBP 0.759936
GEL 2.70504
GGP 0.759642
GHS 10.930743
GIP 0.759642
GMD 73.000355
GNF 8677.076622
GTQ 7.659909
GYD 209.133877
HKD 7.77703
HNL 26.282902
HRK 6.514104
HTG 133.048509
HUF 332.660388
IDR 16685.5
ILS 3.24758
IMP 0.759642
INR 88.639504
IQD 1309.474904
IRR 42100.000352
ISK 126.580386
JEP 0.759642
JMD 160.439
JOD 0.70904
JPY 153.43504
KES 129.203801
KGS 87.450384
KHR 4023.264362
KMF 421.00035
KPW 899.998686
KRW 1455.990383
KWD 0.306904
KYD 0.83302
KZT 524.767675
LAK 21703.220673
LBP 89512.834262
LKR 304.684561
LRD 182.526573
LSL 17.315523
LTL 2.95274
LVL 0.60489
LYD 5.458091
MAD 9.265955
MDL 17.042585
MGA 4492.856402
MKD 53.206947
MMK 2099.464216
MNT 3582.836755
MOP 8.007472
MRU 39.595594
MUR 45.910378
MVR 15.405039
MWK 1733.369658
MXN 18.44605
MYR 4.176039
MZN 63.950377
NAD 17.315148
NGN 1436.000344
NIO 36.782862
NOK 10.153804
NPR 141.758018
NZD 1.777162
OMR 0.38142
PAB 0.999671
PEN 3.37342
PGK 4.220486
PHP 58.805504
PKR 282.656184
PLN 3.665615
PYG 7072.77311
QAR 3.643196
RON 4.398804
RSD 102.170373
RUB 80.869377
RWF 1452.42265
SAR 3.750713
SBD 8.230592
SCR 13.652393
SDG 600.503676
SEK 9.528504
SGD 1.301038
SHP 0.750259
SLE 23.203667
SLL 20969.499529
SOS 571.228422
SRD 38.599038
STD 20697.981008
STN 21.189281
SVC 8.746265
SYP 11056.879504
SZL 17.321588
THB 32.395038
TJS 9.226139
TMT 3.51
TND 2.954772
TOP 2.342104
TRY 42.211304
TTD 6.77604
TWD 30.981804
TZS 2455.000335
UAH 41.915651
UGX 3498.408635
UYU 39.809213
UZS 12055.19496
VES 228.194038
VND 26310
VUV 122.189231
WST 2.820904
XAF 567.301896
XAG 0.020687
XAU 0.00025
XCD 2.70255
XCG 1.801521
XDR 0.707015
XOF 567.306803
XPF 103.14423
YER 238.503589
ZAR 17.29905
ZMK 9001.203584
ZMW 22.615629
ZWL 321.999592
  • RBGPF

    -0.7800

    75.22

    -1.04%

  • SCS

    0.0000

    15.76

    0%

  • NGG

    1.4600

    77.75

    +1.88%

  • VOD

    0.2400

    11.58

    +2.07%

  • RELX

    -1.1200

    42.27

    -2.65%

  • RIO

    0.0600

    69.33

    +0.09%

  • RYCEF

    0.0800

    14.88

    +0.54%

  • BCC

    -0.0900

    70.64

    -0.13%

  • BTI

    0.3800

    54.59

    +0.7%

  • GSK

    -0.4700

    46.63

    -1.01%

  • CMSD

    0.0900

    24.1

    +0.37%

  • CMSC

    0.0700

    23.85

    +0.29%

  • JRI

    -0.0100

    13.74

    -0.07%

  • BCE

    0.0200

    23.19

    +0.09%

  • AZN

    0.8100

    84.58

    +0.96%

  • BP

    0.7600

    36.58

    +2.08%

US abortion ruling threatens access to arthritis drug
US abortion ruling threatens access to arthritis drug / Photo: © POOL/AFP/File

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Text size:

"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.

Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.

"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.

Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.

It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.

"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.

The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.

Methotrexate stops cell division and is given in higher doses as a cancer drug.

It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.

Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.

- 'It's terrifying' -

Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.

A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.

She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.

Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.

A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."

Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.

Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.

In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.

CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."

Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.

"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.

Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.

"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.

F.Brown--ThChM